Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eradication of nasal Staphylococcus aureus carriage with mupirocin in ICU staff
IRCT2014102519666N1Phase 2Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- May 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of mupirocin in Staphylococcus aureus infection, sponsored by Golestan University of Medical Sciences. Started May 2014; status: completed.
02
Drugs
mupirocin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on IRCT2014102519666N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014102519666N1.